{"database": "lobbying", "table": "lobbying_activities", "rows": [[2467115, "175067de-9e50-4fb5-8e80-be44317a7487", "Q2", "LUNGREN LOPINA LLC", 401103314, "AMPAC FINE CHEMICALS", 2020, "second_quarter", "PHA", "Fair treatment for US based pharmaceutical ingredients", "Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-07-15T18:16:26.827000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2467115"], "units": {}, "query_ms": 0.45273301657289267, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}